NEW YORK, Oct. 13 (UPI) -- A New York federal appeals court has revived a lawsuit against Pfizer Inc. over its study on Nigerian children, the Wall Street Journal reports.
The suit alleges the pharmaceutical company improperly conducted a clinical study of an experimental antibiotic treating Nigerian children stricken with meningitis.
The plaintiffs include more than two dozen Nigerian families who seek unspecified damages.
They allege their children were injured or died because Pfizer didn't adequately inform them of the risks and alternatives for treatment with Trovan during a 1996 meningitis outbreak.
Last year, a federal judge in New York threw out the case, siding with a Pfizer motion that the U.S. courts were not appropriate or convenient for the trial.
A three-judge panel for the U.S. Court of Appeals for the Second Circuit overturned it and remanded the case to the district court.
A Pfizer spokesman said company personnel acted in accordance with accepted international practice concerning clinical trials.
